World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
111
Citations
79109
World Ranking
5227
National Ranking
2822

Research.com Recognitions

  • 2008 - Fellow of the American Association for the Advancement of Science (AAAS)

Overview

Bruce D. Cheson is affiliated with Georgetown University in the United States and has contributed extensively to medical research, primarily focusing on oncology and related fields. Their work centers on the study and treatment of lymphomas and leukemias, with an emphasis on chronic lymphocytic leukemia and lymphoma diagnosis and treatment.

The scientist's main fields of study include Medicine, with significant publications in Genetics, Pathology and Forensic Medicine, Oncology, Radiology, Nuclear Medicine and Imaging, and Public Health, Environmental and Occupational Health.

Topics covered in their research span:

  • Chronic Lymphocytic Leukemia Research
  • Lymphoma Diagnosis and Treatment
  • CAR-T cell therapy research
  • Viral-associated cancers and disorders
  • Acute Lymphoblastic Leukemia research
  • Cutaneous lymphoproliferative disorders research
  • Cancer-related gene regulation

They have published in multiple scientific venues, most frequently in:

  • Blood
  • Journal of Clinical Oncology
  • Blood and Lymphatic Cancer Targets and Therapy
  • Blood Cancer Journal
  • Cancer Management and Research

Recent papers authored or co-authored by Bruce D. Cheson include:

  • "Umbralisib, a Dual PI3Kδ/CK1ε Inhibitor in Patients With Relapsed or Refractory Indolent Lymphoma" (2021), Journal of Clinical Oncology
  • "Diffuse large B-cell lymphoma: new targets and novel therapies" (2021), Blood Cancer Journal
  • "Copanlisib in the Treatment of Relapsed Follicular Lymphoma: Utility and Experience from the Clinic" (2021), Cancer Management and Research
  • "Tazemetostat in relapsed/refractory follicular lymphoma: a propensity score-matched analysis of E7438-G000-101 trial outcomes" (2022), Oncotarget
  • "Application of the Lugano Classification for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The PRoLoG Consensus Initiative (Part 2-Technical)" (2022), Journal of Nuclear Medicine

Frequent co-authors collaborating with Bruce D. Cheson include:

  • Gilles Salles
  • Ayushi Chauhan
  • David Proudman
  • Deepshekhar Gupta
  • Dave Nellesen

In recognition of their contributions to science, Bruce D. Cheson was named a Fellow of the American Association for the Advancement of Science (AAAS) in 2008.

Best Publications

  • Revised response criteria for malignant lymphoma

    Bruce D. Cheson;Beate Pfistner;Malik E. Juweid;Randy D. Gascoyne

  • Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification

    Bruce D. Cheson;Richard I. Fisher;Sally F. Barrington;Franco Cavalli

  • Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute–Working Group 1996 guidelines

    Michael Hallek;Bruce D. Cheson;Daniel Catovsky;Federico Caligaris-Cappio

  • Report of an International Workshop to Standardize Response Criteria for Non-Hodgkin's Lymphomas

    B D Cheson;S J Horning;B Coiffier;M A Shipp

  • Revised Recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia

    Bruce D. Cheson;John M. Bennett;Kenneth J. Kopecky;Thomas Büchner

  • National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: Revised guidelines for diagnosis and treatment

    Bruce D. Cheson;John M. Bennett;Michael Grever;Neil Kay

  • Idelalisib and rituximab in relapsed chronic lymphocytic leukemia.

    Richard R. Furman;Jeff P. Sharman;Steven E. Coutre;Bruce D. Cheson

  • Clinical application and proposal for modification of the International Working Group (IWG) response criteria in myelodysplasia

    Bruce D. Cheson;Peter L. Greenberg;John M. Bennett;Bob Lowenberg

  • iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL

    Michael Hallek;Bruce D. Cheson;Daniel Catovsky;Federico Caligaris-Cappio

  • Results of a Pivotal Phase II Study of Brentuximab Vedotin for Patients With Relapsed or Refractory Hodgkin's Lymphoma

    Anas Younes;Ajay K. Gopal;Scott E. Smith;Stephen M. Ansell

  • Use of Positron Emission Tomography for Response Assessment of Lymphoma: Consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma

    Malik E. Juweid;Sigrid Stroobants;Otto S. Hoekstra;Felix M. Mottaghy

  • Role of Imaging in the Staging and Response Assessment of Lymphoma: Consensus of the International Conference on Malignant Lymphomas Imaging Working Group

    Sally F. Barrington;N. George Mikhaeel;Lale Kostakoglu;Michel Meignan

  • Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia.

    Andreas Rosenwald;Ash A. Alizadeh;George Widhopf;Richard Simon

  • Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia

    Kanti R. Rai;Bercedis L. Peterson;Frederick R. Appelbaum;Jonathan Kolitz

  • Report of the National Cancer Institute-sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia.

    B D Cheson;P A Cassileth;D R Head;C A Schiffer

  • Report of an international working group to standardize response criteria for myelodysplastic syndromes

    B. D. Cheson;J. M. Bennett;Hagop M Kantarjian;A. Pinto

  • Positron-Emission Tomography and Assessment of Cancer Therapy

    Malik E. Juweid;Bruce D. Cheson

  • Progress and Promise of FDG-PET Imaging for Cancer Patient Management and Oncologic Drug Development

    Gary J. Kelloff;John M. Hoffman;Bruce Johnson;Howard I. Scher

  • Superiority of tandem autologous transplantation over standard therapy for previously untreated multiple myeloma.

    Bart Barlogie;Sundar Jagannath;David H. Vesole;Sally Naucke

  • Total Therapy With Tandem Transplants for Newly Diagnosed Multiple Myeloma

    B. Barlogie;S. Jagannath;K.R. Desikan;S. Mattox

Frequent Co-Authors

Nancy L. Bartlett
Nancy L. Bartlett Washington University in St. Louis
Jonathan W. Friedberg
Jonathan W. Friedberg University of Rochester
John P. Leonard
John P. Leonard Cornell University
Jeffrey L. Johnson
Jeffrey L. Johnson LAC+USC Medical Center
Thomas J. Kipps
Thomas J. Kipps University of California, San Diego
Eric D. Hsi
Eric D. Hsi Cleveland Clinic
Richard R. Furman
Richard R. Furman NewYork–Presbyterian Hospital
Ranjana H. Advani
Ranjana H. Advani Stanford University
Andrew D. Zelenetz
Andrew D. Zelenetz Memorial Sloan Kettering Cancer Center
Susan O'Brien
Susan O'Brien University of California, Irvine

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Considering a career in Medicine doesn't always mean becoming a doctor. There are several related online degree programs that offer flexible study options and open doors to rewarding careers in healthcare. For those interested in health services, pursuing the cheapest online health science degree can provide a strong foundation in topics like public health, healthcare policy, and patient care management.

If you wish to move into leadership roles, you might explore the cheapest online mha programs (Master of Healthcare Administration). These programs prepare graduates for advanced administrative positions within hospitals and healthcare systems.

Nurses aiming for the highest levels of clinical leadership should look into the most affordable dnp programs (Doctor of Nursing Practice). Earning a DNP can mean new opportunities in advanced practice, research, and education.

Aspiring pharmacists may consider pharm d online programs. These online PharmD programs make it easier for students to balance professional aspirations with personal commitments while working towards a high-demand career.

Exploring these online pathways can help you discover the best route to a successful career in healthcare, even if you decide not to attend medical school.

Best Scientists Citing Bruce D. Cheson

Trending Scientists

Recently Published Articles